Gut Microbiota and Ischemic Stroke: The Role of Trimethylamine N-Oxide

키워드

참고문헌 (53)

1. Aron-wisnewsky J, "Dietary choline derived TMAO: new role in thrombosis", AME Med J, 2, pp.112~ (2017)
2. Winek K, "Role of the gut microbiota in ischemic stroke", Neurol Int Open, 1, pp.E287~E293 (2017)
3. Suzuki T, "Trimethylamine N-oxide and risk stratification after acute myocardial infarction", Clin Chem, 63, pp.420~428 (2017)
4. Suk Jae Kim, "Biomarkers for Stroke", 대한뇌졸중영문학회지, 15(1), pp.27~37 (2013), 대한뇌졸중학회[DOI]
5. Evgeny Sidorov, "Biomarker for Ischemic Stroke Using Metabolome: A Clinician Perspective", 대한뇌졸중영문학회지, 21(1), pp.31~41 (2019), 대한뇌졸중학회[DOI]
6. Wu C, "Elevated trimethylamine N-oxide related to ischemic brain lesions after carotid artery stenting", Neurology, 90, pp.e1283~e1290 (2018)
7. Tang WH, "Intestinal microbial metabolism of phosphatidylcholine and cardiovascular risk", N Engl J Med, 368, pp.1575~1584 (2013)
8. Velasquez MT, "Trimethylamine N-oxide: the good, the bad and the unknown", Toxins, 8, pp.E326~ (2016)
9. Cho CE, "Trimethylamine-N-oxide (TMAO) response to animal source foods varies among healthy young men and is influenced by their gut microbiota composition: a randomized controlled trial", Mol Nutr Food Res, 61, pp.1600324~ (2017)
10. Miao J, "Flavin-containing monooxygenase 3 as a potential player in diabetes-associated atherosclerosis", Nat Commun, 6, pp.6498~ (2015)
11. Shih DM, "Flavin containing monooxygenase 3 exerts broad effects on glucose and lipid metabolism and atherosclerosis", J Lipid Res, 56, pp.22~37 (2015)
12. Komaroff AL, "The microbiome and risk for atherosclerosis", JAMA, 319, pp.2381~2382 (2018)
13. Loscalzo J, "Gut microbiota, the genome, and diet in atherogenesis", N Engl J Med, 368, pp.1647~1649 (2013)
14. Ferguson JF, "Nutrigenomics, the microbiome, and gene-environment interactions: new directions in cardiovascular disease research, prevention, and treatment: a scientific statement from the American Heart Association", Circ Cardiovasc Genet, 9, pp.291~313 (2016)
15. Senthong V, "Trimethylamine N-oxide and mortality risk in patients with peripheral artery disease", J Am Heart Assoc, 5, pp.e004237~ (2016)
16. Miller CA, "Effect of egg ingestion on trimethylamine-N-oxide production in humans: a randomized, controlled, dose-response study", Am J Clin Nutr, 100, pp.778~786 (2014)
17. Cho CE, "Trimethylamine-N-oxide: friend, foe, or simply caught in the cross-fire?", Trends Endocrinol Metab, 28, pp.121~130 (2017)
18. Boutagy NE, "Short-term high-fat diet increases postprandial trimethylamine-N-oxide in humans", Nutr Res, 35, pp.858~864 (2015)
19. Nie J, "Serum trimethylamine N-oxide concentration is positively associated with first stroke in hypertensive patients", Stroke, 49, pp.2021~2028 (2018)
20. Yin J, "Dysbiosis of gut microbiota with reduced trimethylamine-n-oxide level in patients with large-artery atherosclerotic stroke or transient ischemic attack", J Am Heart Assoc, 4, pp.e002699~ (2015)
21. Randrianarisoa E, "Relationship of serum trimethylamine N-oxide (TMAO) levels with early atherosclerosis in humans", Sci Rep, 6, pp.26745~ (2016)
22. Svingen GFT, "Increased plasma trimethylamine-N-oxide is associated with incident atrial fibrillation", Int J Cardiol, 267, pp.100~106 (2018)
23. Tang WH, "Increased trimethylamine N-oxide portends high mortality risk independent of glycemic control in patients with type 2 diabetes mellitus", Clin Chem, 63, pp.297~306 (2017)
24. Papandreou C, "Plasma trimethylamine-N-oxide and related metabolites are associated with type 2 diabetes risk in the Prevención con Dieta Mediterránea (PREDIMED) trial", Am J Clin Nutr, 108, pp.163~173 (2018)
25. Fu Q, "Coronary plaque characterization assessed by optical coherence tomography and plasma trimethylamine-N-oxide levels in patients with coronary artery disease", Am J Cardiol, 118, pp.1311~1315 (2016)
26. Tan Y, "Plasma Trimethylamine N-oxide as a novel biomarker for plaque rupture in patients with ST-segment-elevation myocardial infarction", Circ Cardiovasc Interv, 12, pp.e007281~ (2019)
27. Suzuki T, "Trimethylamine N-oxide and prognosis in acute heart failure", Heart, 102, pp.841~848 (2016)
28. Kanitsoraphan C, "Trimethylamine N-oxide and risk of cardiovascular disease and mortality", Curr Nutr Rep, 7, pp.207~213 (2018)
29. Trøseid M, "Microbiota-dependent metabolite trimethylamine-N-oxide is associated with disease severity and survival of patients with chronic heart failure", J Intern Med, 277, pp.717~726 (2015)
30. Tang WH, "Prognostic value of elevated levels of intestinal microbe-generated metabolite trimethylamine-N-oxide in patients with heart failure: refining the gut hypothesis", J Am Coll Cardiol, 64, pp.1908~1914 (2014)
31. Bain MA, "Accumulation of trimethylamine and trimethylamine-N-oxide in end-stage renal disease patients undergoing haemodialysis", Nephrol Dial Transplant, 21, pp.1300~1304 (2006)
32. Missailidis C, "Serum trimethylamine-N-oxide is strongly related to renal function and predicts outcome in chronic kidney disease", PLoS One, 11, pp.e0141738~ (2016)
33. Kim RB, "Advanced chronic kidney disease populations have elevated trimethylamine N-oxide levels associated with increased cardiovascular events", Kidney Int, 89, pp.1144~1152 (2016)
34. Li D, "Trimethylamine-N-oxide promotes brain aging and cognitive impairment in mice", Aging Cell, 17, pp.e12768~ (2018)
35. Vogt NM, "The gut microbiota-derived metabolite trimethylamine N-oxide is elevated in Alzheimer’s disease", Alzheimers Res Ther, 10, pp.124~ (2018)
36. Wang Z, "Gut flora metabolism of phosphatidylcholine promotes cardiovascular disease", Nature, 472, pp.57~63 (2011)
37. Gregory JC, "Transmission of atherosclerosis susceptibility with gut microbial transplantation", J Biol Chem, 290, pp.5647~5660 (2015)
38. Zhu W, "Gut microbial metabolite TMAO enhances platelet hyperreactivity and thrombosis risk", Cell, 165, pp.111~124 (2016)
39. Koeth RA, "Intestinal microbiota metabolism of L-carnitine, a nutrient in red meat, promotes atherosclerosis", Nat Med, 19, pp.576~585 (2013)
40. Seldin MM, "Trimethylamine N-oxide promotes vascular inflammation through signaling of mitogen-activated protein kinase and nuclear factor-κB", J Am Heart Assoc, 5, pp.e002767~ (2016)
41. Sun X, "Trimethylamine N-oxide induces inflammation and endothelial dysfunction in human umbilical vein endothelial cells via activating ROS-TXNIP-NLRP3 inflammasome", Biochem Biophys Res Commun, 481, pp.63~70 (2016)
42. Wang Z, "Measurement of trimethylamine-N-oxide by stable isotope dilution liquid chromatography tandem mass spectrometry", Anal Biochem, 455, pp.35~40 (2014)
43. Skagen K, "The carnitine-butyrobetaine-trimethylamine-N-oxide pathway and its association with cardiovascular mortality in patients with carotid atherosclerosis", Atherosclerosis, 247, pp.64~69 (2016)
44. Meyer KA, "Microbiota-dependent metabolite trimethylamine N-oxide and coronary artery calcium in the coronary artery risk development in young adults study (CARDIA)", J Am Heart Assoc, 5, pp.e003970~ (2016)
45. Ma J, "Microscopic insights into the proteinstabilizing effect of trimethylamine N-oxide (TMAO)", Proc Natl Acad Sci U S A, 111, pp.8476~8481 (2014)
46. Collins HL, "L-Carnitine intake and high trimethylamine N-oxide plasma levels correlate with low aortic lesions in ApoE(-", -) transgenic mice expressing CETP, 2016, pp.244, 29~37
47. Yoshida N, "Gut microbiome and cardiovascular diseases", Diseases, 6, pp.E56~ (2018)
48. Chen J, "Physical exercise, gut, gut microbiota, and atherosclerotic cardiovascular diseases", Lipids Health Dis, 17, pp.17~ (2018)
49. Zhang H, "Trimethylamine N-oxide supplementation abolishes the cardioprotective effects of voluntary exercise in mice fed a western diet", Front Physiol, 8, pp.944~ (2017)
50. Zhu W, "Gut microbe-generated trimethylamine N-oxide from dietary choline is prothrombotic in subjects", Circulation, 135, pp.1671~1673 (2017)
51. Chen ML, "Resveratrol attenuates trimethylamine-N-oxide (TMAO)-induced atherosclerosis by regulating TMAO synthesis and bile acid metabolism via remodeling of the gut microbiota", MBio, 7, pp.e02210~e02215 (2016)
52. Kuka J, "Suppression of intestinal microbiota-dependent production of pro-atherogenic trimethylamine N-oxide by shifting L-carnitine microbial degradation", Life Sci, 117, pp.84~92 (2014)
53. Wang Z, "Non-lethal inhibition of gut microbial trimethylamine production for the treatment of atherosclerosis", Cell, 163, pp.1585~1595 (2015)

관련 논문AI추천